WNK4 Intron 10 Polymorphism Is Not Associated with Hypertension

Hypertension

Volumn 43, Issue 4, 2004, Pages 766-768

  Speirs, Helen J L ^a   Morris, Brian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Genetics; Hypertension, essential; Kinase; Polymorphism; Sodium transport

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM; TRIACYLGLYCEROL;

ADULT; ALLELISM; AMINO ACID SUBSTITUTION; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; ESSENTIAL HYPERTENSION; ETHNIC DIFFERENCE; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE WNK4; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INTRON; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM TRANSPORT; UNITED KINGDOM;

ADULT; AUSTRALIA; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HAPLOTYPES; HUMANS; HYPERTENSION; INTRONS; ION TRANSPORT; IRELAND; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; SODIUM;

EID: 1642542443     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000120121.43524.cd     Document Type: Article

References (26)

1. Julier C, Delepine M, Keavney B, Terwilliger J, Davis S, Weeks DE, Bui T, Jeunemaitre X, Velho G, Froguel P, Ratcliffe P, Corvol P, Soubrier F, Lathrop GM. Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Med Genet. 1997;6:2077-2086.
2. Baima J, Nicolaou M, Schwartz F, DeStefano AL, Manolis A, Gavras I, Laffer C, Elijovich F, Farrer L, Baldwin CT, Gavras H. Evidence for linkage between essential hypertension and a putative locus on human chromosome 17. Hypertension. 1999:34:4-7.
3. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension. 2000;36:477-483.
4. Hilbert P, Lindpainter K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Canwright P, De Gouyen B, Julier C, Takahashi S, Vincent M, D. Ganten D, Georges M, Lathrop GM. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature. 1991;353:521-529.
5. Jacob HJ, Lindpainter K, Lincoln SE, Kusumi K, Bunker RK, Mao Y-P, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67: 213-224.
6. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard J-M, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-1112.
7. Zhu H, Sagnella GA, Dong Y, Miller MA, Onipinla A, Markandu ND, MacGregor GA. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens. 2003;21:87-95.
8. Kumar N, Benjafield AV, Lin RCY, Wang WYS, Stowasser M, Morris BJ. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens. 2003;21: 1331-1337.
9. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel J-M. A chimeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
10. Morris BJ. Molecular genetics in childhood hypertension (review). Prog Pediat Cardiol. 1999;9:203-212.
11. Baker EH, Dong YB, Sagnella GA, Roghwell M, Onnipinla AK, Markandu ND, Cappuccio FP, Cook DG, Persu A, Corvol P. Association of hypertension with T594M mutation in β subunit of epithelial sodium channels in black people resident in London. Lancet. 1998;351:1388-1392.
12. + channel in essential hypertension. J Hypertens. 1999;17:639-645.
13. + channel: progressing from Liddle's syndrome to essential hypertension (Editorial comment). J Hypertens. 2003;21:855-857.
14. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nat Genet. 1995;11:76-82.
15. Erlich PM, Cui J, Chazaro I, Farrer, L. A., Baldwin CT, Gavras H, DeStefano AL. Genetic variants of WNK4 in whiles and African Americans with hypertension. Hypertension. 2003;41:1191-1195.
16. Wang WYS, Zee RYL, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet. 1997; 51:31-34.
17. Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential hypertension. Nature Genet. 1996;12:122.
18. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein β3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension. 1998;32:1094-1097.
19. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-1089.
20. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity. 1974;33:229-239.
21. Weeks DE, Lathrop M. Polygenic disease: methods for mapping complex disease traits. Trends Genet. 1995;11:513-519.
22. Benjafield AV, Katyk K, Morris BJ. Association of EDNRA, but not WNK4 or FKBPIB, polymorphisms with essential hypertension. Clin Genet. 2003;63.
23. Monti J, Zimdahl H, Schulz H, Plehm R, Ganten D, Hubner N. The role of Wnk4 in polygenic hypertension: a candidate gene analysis on rat chromosome 10. Hypertension. 2003;41:938-942.
24. Morris BJ, Benjafield AV, Lin RCY. Essential hypertension: Genes and dreams. Clin Chem Lab Med. 2003;41:834-844.
25. Knight J, Munroe PB, Pembroke JC, Caulfield M. Human chromosome 17 in essential hypertension. Ann Hum Genet 2003;67:193-206.
26. Caulfield M, Munroe P, Samani N, Pembroke J, Dominiczak A, Brown M, Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, Newhouse S, Hooper J, Lee W, Brain N, Clayton D, Lathrop M, Farrall M, Connell J. Genome-wide mapping for human loci for essential hypertension. Lancet. 2003;361:2118-2123.